… surface area for drug absorption. An inhaled form of insulin (Exubera) was available … and Drug Administration (FDA) approved a new formulation of inhaled insulin (Afrezza … . Does inhaled insulin obviate the need for injections? Inhaled insulin is only …

… people with diabetes, as drugmaker Cipla completes last mile … Recently, India’s Central Drugs Standard Control Organisation gave Cipla … Hospital, Hebbal agreed that inhaled insulin “adds a layer of … in the past -- from Pfizer (Exubera) and Sanofi ( Afrezza) – …

… against several pharmaceutical firms, including Pfizer, Boehringer Ingelheim, and Sanofi, apart … drug. Also Read: Cipla set to bring Afrezza, 1st inhalable insulin since Exubera … Medicines (NELM). This list includes drugs used in treating diseases considered …

… created a pain-free drug delivery method to help … -clinical tests showed that insulin with the peptide effectively reaches … whereas without the peptide, insulin remains stuck in the inside … run." An inhalable insulin product, Exubera, was briefly on the …

… created a pain-free drug delivery method to help … -clinical tests showed that insulin with the peptide effectively … whereas without the peptide, insulin remains stuck in the … run." Two inhalable insulin products (Exubera, Afrezza) were approved earlier …

… created a pain-free drug delivery method to help … -clinical tests showed that insulin with the peptide effectively … whereas without the peptide, insulin remains stuck in the … long run.” Two inhalable insulin products (Exubera, Afrezza) were approved earlier …

… created a pain-free drug delivery method to help … created a pain-free drug delivery method to help … -clinical tests showed that insulin with the peptide effectively reaches … long run.” Two inhalable insulin products (Exubera, Afrezza) were approved earlier …

… the market: Afrezza and Exubera. However, Exubera was discontinued due to poor … emphasizing the need for diverse insulin delivery methods. Moreover, technological … alternative and witnessing advancements in drug delivery technology. Distribution Channels …

… expectations. Industry publications predicted Exubera would yield Pfizer $1.5 billion in … change in the delivery of insulin,” West said. “But according to … of blister packs into the inhaler,” West said. Healthcare providers were …

… from the traditional injectable insulin market. Therefore, there … forms of insulin. Hence, oral insulin will always … 2006, Pfizer launched the world’s first inhaled insulin, Exubera, but … barely a year later, it withdrew Exubera …